Company Monitoring Page for Roche

latest headlines for company on cafepharma

Thu, 03/7/19 - 09:35 am
Tags:
Genentech, Roche, AbbVie, chronic lymphocytic leukemia, Gazyva, Venclexta
Top 10 drugs losing exclusivity in 2019
Fierce Pharma
Tue, 03/5/19 - 09:40 am
Tags:
market exclusivity, patents, Rituxan, Lyrica, Herceptin, Avastin, Epclusa, Harvoni, Pfizer, Roche, Gilead Sciences, Amgen, GSK, Allergan, Individor
Sanofi, Bayer and Roche execs underscore the value of digital therapeutics
MedCity
Sat, 03/2/19 - 12:47 pm
Tags:
digital therapeutics, Sanofi, Bayer, Roche
Roche wins US approval of more convenient Herceptin
Biopharma Dive
Sat, 03/2/19 - 12:03 am
Tags:
Roche, Herceptin, breast cancer
Big Pharma aces brand valuations for 2019, with Roche once again leading the way
Fierce Pharma
Wed, 02/27/19 - 11:03 am
Tags:
brand valuation, Roche
Celgene gets fast FDA review of Revlimid combo in lymphoma
Pharmaforum
Wed, 02/27/19 - 10:49 am
Tags:
Celgene, Revlimid, FDA, Roche, Rituxan, priority review
Can Roche’s little tech startup help the FDA change clinical trials?
Stat
Mon, 02/25/19 - 11:34 pm
Tags:
FDA, Roche, clinical trials, Flatiron Health
Roche Bets $4.8B on Spark Therapeutics and the Future of Gene Therapy
Xconomy
Mon, 02/25/19 - 10:00 am
Tags:
Roche, gene therapy, Spark Therapeutics, M&A
IP trouble defers launch of Novo's long-acting hemophilia therapy
Endpoints
Wed, 02/20/19 - 10:03 am
Tags:
Novo Nordisk, Eseproct, hemophilia, Roche, Hemlibra
2 Pharma Stocks in the Middle of an Oncology Sales Explosion
Motley Fool
Tue, 02/19/19 - 08:01 pm
Tags:
oncology, Roche, AbbVie, AstraZeneca
As generic competition stutter sales of top oncology drugs, Roche secures speedy review for pair of experimental cancer offerings
Endpoints
Tue, 02/19/19 - 12:15 pm
Tags:
Roche, Seattle Genetics, generics, antibody-drug conjugate, polatuzumab vedotin, relapsed or refractory diffuse large B-cell lymphoma, entrectinib, solid tumors
Executive Provides Mentorship and Promotes Diversity at Genentech
BioSpace
Mon, 02/18/19 - 07:44 pm
Tags:
diversity, Genentech, Roche
Layoffs Hit California Biopharma Companies
BioSpace
Mon, 02/18/19 - 11:49 am
Tags:
layoffs, Roche, Genentech, Pfizer, Aduro BioTech, Theravance, Merck
Hurricanes, droughts, and wildfires: How biopharma is girding for climate change
Stat
Fri, 02/15/19 - 10:29 am
Tags:
climate change, natural disasters, tropical diseases, Takeda, AbbVie, Roche
Pharma companies clear the R&D decks in Q4
Pharmaforum
Mon, 02/11/19 - 12:20 pm
Tags:
R&D, GSK, Sanofi, Eli Lilly, Roche, Gilead Sciences
Genentech Plans Legal Battle to Protect Esbriet from Generic Competition
BioSpace
Tue, 02/5/19 - 11:19 pm
Tags:
Genentech, Roche, idiopathic pulmonary fibrosis, Esbriet, generics
Roche seeks FDA approval for Kadcyla in HER2-positive early breast cancer
Pharmaceutical Business Review
Tue, 02/5/19 - 10:18 am
Tags:
Roche, FDA, Kadcyla, HER2-positive early breast cancer
Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance
Yahoo/Zacks.com
Sat, 02/2/19 - 12:24 pm
Tags:
Roche, earnings
Report: five companies would take brunt of Trump Part B proposal
BioCentury
Fri, 02/1/19 - 11:24 am
Tags:
Donald Trump, Medicare Part B, Amgen, Regeneron, Bristol-Myers Squibb, Genentech, Roche
All Eyes on Biogen as Roche Alzheimer’s Drug Flunks Final Test
Xconomy
Wed, 01/30/19 - 11:56 am
Tags:
Roche, Alzheimer's disease, clinical trials, AC Immune, crenezumab, Biogen, aducanumab

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.